TIDMHIK

RNS Number : 9314J

Hikma Pharmaceuticals Plc

16 April 2020

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Conditional Shares acquired from the grant made 
       transaction               on 13 April 2017 and vested on 14 April 2020 
                                 under the 2014 EIP Element C. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 36,438 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   15 April 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Conditional Shares acquired from the grant made 
       transaction               on 13 April 2017 and vested on 14 April 2020 
                                 under the 2014 EIP Element C. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 19,318 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   15 April 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Majda Labadi

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Majda Labadi 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Conditional Shares acquired from the grant made 
     transaction              on 13 April 2017 and vested on 14 April 2020 
                              under the 2014 EIP Element C. 
c)  Price(s) and             Price(s): GBPnil 
     volume(s)                Volume(s): 16,146 
d)  Aggregated information   N/A 
e)  Date of the transaction  15 April 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Riad Mishlawi

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Riad Mishlawi 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Conditional Shares acquired from the grant made 
     transaction              on 13 April 2017 and vested on 14 April 2020 
                              under the 2014 EIP Element C. 
c)  Price(s) and             Price(s): GBPnil 
     volume(s)                Volume(s): 20,146 
d)  Aggregated information   N/A 
e)  Date of the transaction  15 April 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Conditional Shares acquired from the grant made 
       transaction               on 13 April 2017 and vested on 14 April 2020 
                                 under the 2014 EIP Element C. 
 c)   Price(s) and              Price(s): GBP22.82 
       volume(s)                 Volume(s): 23,233 
 d)   Aggregated information   Number of Shares: 23,233 
                                Price: GBP530,177 
 e)   Date of the transaction   14 April 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Conditional Shares acquired from the grant made 
       transaction               on 13 April 2017 and vested on 14 April 2020 
                                 under the 2014 EIP Element C. 
 c)   Price(s) and              Price(s): GBP22.82 
       volume(s)                 Volume(s): 23,751 
 d)   Aggregated information   Number of Shares: 23,751 
                                Price: GBP541,998 
 e)   Date of the transaction   14 April 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Susan Ringdal

 
a)  Name                     Susan Ringdal 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Shares acquired from the exercise of nil-cost 
     transaction              options granted on 17 May 2013 and 11 June 2014 
                              under the 2007 LTIP and nil-cost options granted 
                              on 10 April 2015 under the 2014 EIP Elements 
                              B and C 
c)  Price(s) and              Share Plan    Price       Volume 
     volume(s)                 2013 LTIP     GBP22.82    18,424 
                                            ----------  ------- 
                               2014 LTIP     GBP22.82    11,774 
                                            ----------  ------- 
                               2015 EIP B    GBP22.82    6,006 
                                            ----------  ------- 
                               2015 EIP C    GBP22.82    6,006 
                                            ----------  ------- 
d)  Aggregated information   Number of Shares: 42,210 
                              Price: GBP963,232 
e)  Date of the transaction  15 April 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Brian Hoffmann

 
a)  Name                     Brian Hoffmann 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Shares acquired from the vesting of nil-cost 
     transaction              options granted on 11 May 2016 and 13 April 
                              2017 under the 2014 EIP Element B. 
c)  Price(s) and              Share Plan    Price       Volume 
     volume(s)                 2016 EIP B    GBP22.34    8,230 
                                            ----------  ------- 
                               2017 EIP B    GBP22.34    9,327 
                                            ----------  ------- 
d)  Aggregated information   Number of Shares: 17,557 
                              Price: GBP392,223 
e)  Date of the transaction  16 April 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 
 
a)  Name                     Brian Hoffmann 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Disposal of Shares. 
     transaction 
c)  Price(s) and             Price(s): GBP22.79 
     volume(s)                Volume(s): 2,219 
d)  Aggregated information   Number of Shares: 2,219 
                              Price: GBP50,571 
e)  Date of the transaction  14 April 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

16 April 2020

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBSGDSUGBDGGL

(END) Dow Jones Newswires

April 16, 2020 10:07 ET (14:07 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Ott 2020 a Nov 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Nov 2019 a Nov 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals